In this presentation, Professor Mike Shuler details his work to understand the response of the human body to various pharmaceutical and environmental chemicals using a combination of whole body modules and micro models Professor Shuler’s research focuses on microfabricated devices combined with cell cultures. This combination provides a viable alternative to animal models to predict toxicity and response to pharmaceuticals. To date his models of the GI tract have been used to examine the response to oral exposure of drugs, chemicals, and nanoparticles. These coupled GI tract/body modules have been used to mimic human response to acetaminophen plus ethanol and have shown that nanoparticles can interfere with normal physiological responses such as iron uptake and nutrition. View this webinar to learn more about the exciting work being done in the field of predictive pharmacology.
You will be able to download and print a certificate for PDH credits once the content has been viewed.
If you have already viewed this content,
please click here
Michael L. Shuler is the James and Marsha McCormick Chair of the Department of Biomedical Engineering as well as the Samuel B. Eckert Professor of Chemical Engineering in the School of Chemical and Biomolecular Engineering at Cornell University, Ithaca, New York. He was also a NYSTAR Distinguished Professor (2001-2006). Shuler received both of his degrees in chemical engineering (BS, University of Notre Dame, 1969 and PhD., University of Minnesota, 1973) and has been a faculty member at Cornell University since January 1974. Shuler’s research is focused on...Read more
Do you already own this?
Log In for instructions on accessing this
|AIChE Member Credits
|AIChE Undergraduate Student Members
|AIChE Graduate Student Members
Webinar content is available with the kind permission of the author(s) solely for the purpose of furthering AIChE’s mission to educate, inform and improve the practice of professional chemical engineering. All other uses are forbidden without the express consent of the author(s). For permission to re-use, please contact email@example.com